- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12. | Polyrizon Ltd.: Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program | 261 | GlobeNewswire (Europe) | Ra'anana, Israel, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ("Polyrizon" or the "Company"), a biotechnology company focusing on the development of intranasal products, today... ► Artikel lesen | |
| 11.12. | Polyrizon Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 08.12. | Polyrizon schließt FDA-Gespräch zu Allergie-Blocker ab - Aktie mit 314 % Wochenplus | 3 | Investing.com Deutsch | ||
| 08.12. | Polyrizon completes FDA pre-submission meeting for allergy blocker | 3 | Investing.com | ||
| 08.12. | Polyrizon Ltd.: Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray | 104 | GlobeNewswire (Europe) | Ra'anana, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ("Polyrizon" or the "Company"), a biotechnology company focusing on the development of intranasal products, today... ► Artikel lesen | |
| 05.12. | Morning Market Movers: SMX, Praxis Precision Medicines, Polyrizon, Rubrik, Inc. See Big Swings | 1.862 | AFX News | HONG KONG (dpa-AFX) - At 7:50 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 04.12. | Polyrizon Stock Skyrockets After New Data Shows Naloxone Gel Outperforms Marketed Spray | 2 | Benzinga.com | ||
| 04.12. | Polyrizon Shares Soar 103% After Manufacturing Milestone Boosts Investor Optimism | 3 | RTTNews | ||
| POLYRIZON Aktie jetzt für 0€ handeln | |||||
| 04.12. | Morning Market Movers: Polyrizon, Picard Medical, Crescent Biopharma, Hyster-Yale See Big Swings | 325 | AFX News | OTTAWA (dpa-AFX) - At 7:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 04.12. | Polyrizon Ltd.: From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection | 5 | GlobeNewswire (USA) | ||
| 04.12. | Polyrizon Surges On Positive Mucoadhesion Results For Naloxone Hydrogel | 7 | RTTNews | ||
| 03.12. | Polyrizon Achieves Scaled Manufacturing Milestone for PL-14 Intranasal Allergy Spray | 8 | Contract Pharma | ||
| 03.12. | Polyrizon's nasal naloxone gel shows stronger mucoadhesion in study | 8 | Investing.com | ||
| 03.12. | Polyrizon Ltd.: Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product | 102 | GlobeNewswire (Europe) | Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra'anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ)... ► Artikel lesen | |
| 02.12. | Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials | 2 | Benzinga.com | ||
| 02.12. | Polyrizon-Aktie explodiert nach Meilenstein bei der Produktionsskalierung | 32 | Investing.com Deutsch | ||
| 02.12. | Polyrizon Ltd.: Polyrizon Announces Successful Completion of Key Manufacturing Upscaling Milestone for Its Nasal Spray Platform | 222 | GlobeNewswire (Europe) | Ra'anana, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ("Polyrizon" or the "Company"), a biotechnology company developing intranasal products based on its proprietary Capture... ► Artikel lesen | |
| 02.12. | Polyrizon Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 25.11. | Polyrizon Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 06.11. | Polyrizon: Nasengel zeigt in Labortests Schutzwirkung gegen H1N1-Virus | 2 | Investing.com Deutsch |
1 2 3 4 Weiter >>
62 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 38,595 | +0,30 % | QIAGEN NV steht still - für mich ist das kein Stillstand! | ||
| NOVAVAX | 5,556 | -0,20 % | Why I Wouldn't Touch Novavax With a 10-Foot Pole | ||
| 4SC | 0,100 | -23,37 % | 4SC AG: Kapitalmaßnahmen mit Delisting ab Mitte Dezember | Die 4SC AG rechnet mit dem zeitnahen Wirksamwerden der von der Hauptversammlung am 19. September 2025 beschlossenen Kapitalmaßnahmen. Konkret soll die Kapitalherabsetzung auf null Euro mit gleichzeitiger... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 22,490 | 0,00 % | Laidlaw initiates coverage on Palatin Technologies stock with Buy rating | ||
| BIOXXMED | 0,023 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 2,240 | +0,90 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 1,610 | -9,55 % | COSCIENS Biopharma Inc. Announces Leadership Change | TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company"), a life science company focused on natural ingredients and pharmaceutical... ► Artikel lesen | |
| XOMA ROYALTY | 21,600 | 0,00 % | XOMA Royalty Corporation Enters into Agreement to Acquire Generation Bio Co. | - Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio's collaboration with Moderna - - Generation Bio's cell-targeted lipid nanoparticles (ctLNP) delivery... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 1,060 | 0,00 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762 | King of Prussia, Pennsylvania--(Newsfile Corp. - November 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its... ► Artikel lesen | |
| MOSAIC IMMUNOENGINEERING | - | - | Mosaic ImmunoEngineering Inc. - 10-Q, Quarterly Report | ||
| T2 BIOSYSTEMS | 0,250 | 0,00 % | NSE/A - T2 Biosystems, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| ORAGENICS | 0,825 | -0,42 % | ORAGENICS INC - 8-K, Current Report | ||
| LADRX | - | - | LadRx Corp - 8-K, Current Report | ||
| UNITY BIOTECHNOLOGY | 0,030 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 10.10.2025 | The following instruments on XETRA do have their last trading day on 10.10.2025Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 10.10.2025ISIN NameDE000DB9U2Y9 DT.BANK IS. 20/25US44891CBN20... ► Artikel lesen | |
| TENAX THERAPEUTICS | 2,770 | -100,00 % | Tenax Therapeutics, Inc.: Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment | Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half... ► Artikel lesen |
POLYRIZON LTD gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 10,200 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLYRIZON LTD finden Sie auf Wallstreet Online.